Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status (Ascending)
63323-0101-61 63323-0101 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 14, 2000 In Use
63323-0883-05 63323-0883 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 14, 2000 In Use
63323-0883-10 63323-0883 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 14, 2000 In Use
63323-0883-30 63323-0883 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 14, 2000 In Use
68083-0248-01 68083-0248 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug. 22, 2017 In Use
68083-0249-01 68083-0249 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug. 22, 2017 In Use
68083-0250-01 68083-0250 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug. 22, 2017 In Use
70121-1219-01 70121-1219 Doxorubicin Hydrochloride Doxorubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 17, 2017 In Use
00310-4500-12 00310-4500 Durvalumab Imfinzi 120.0 mg/2.4mL Immunotherapy Checkpoint Inhibitor PD-L1 Intravenous May 1, 2017 In Use
00310-4611-50 00310-4611 Durvalumab Imfinzi 500.0 mg/10mL Immunotherapy Checkpoint Inhibitor PD-L1 Intravenous May 1, 2017 In Use
00003-2291-11 00003-2291 Elotuzumab Empliciti 300.0 mg/1 Immunotherapy Monoclonal Antibody SLAMF7 Intravenous Nov. 30, 2015 In Use
00003-4522-11 00003-4522 Elotuzumab Empliciti 400.0 mg/1 Immunotherapy Monoclonal Antibody SLAMF7 Intravenous Nov. 30, 2015 In Use
59572-0705-30 59572-0705 Enasidenib mesylate Idhifa 50.0 mg/1 Chemotherapy Enzyme Inhibitor IDH2 Oral Aug. 1, 2017 In Use
59572-0710-30 59572-0710 Enasidenib mesylate Idhifa 100.0 mg/1 Chemotherapy Enzyme Inhibitor IDH2 Oral Aug. 1, 2017 In Use
00469-0125-99 00469-0125 Enzalutamide Xtandi 40.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Aug. 31, 2012 In Use
00009-5091-01 00009-5091 Epirubicin Hydrochloride Ellence 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sept. 15, 1999 In Use
00009-5093-01 00009-5093 Epirubicin Hydrochloride Ellence 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sept. 15, 1999 In Use
00143-9202-01 00143-9202 Epirubicin Hydrochloride Epirubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug. 7, 2007 In Use
00143-9203-01 00143-9203 Epirubicin Hydrochloride Epirubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Aug. 7, 2007 In Use
59762-5091-01 59762-5091 Epirubicin Hydrochloride Epirubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sept. 15, 1999 In Use
59762-5093-01 59762-5093 Epirubicin Hydrochloride Epirubicin Hydrochloride 2.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Sept. 15, 1999 In Use
62856-0389-01 62856-0389 Eribulin mesylate Halaven 0.5 mg/mL Chemotherapy Antimitotic Agent Furopyrans Intravenous Nov. 15, 2010 In Use
50242-0062-01 50242-0062 Erlotinib Hydrochloride Tarceva 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral April 30, 2005 In Use
50242-0063-01 50242-0063 Erlotinib Hydrochloride Tarceva 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral April 30, 2005 In Use
50242-0064-01 50242-0064 Erlotinib Hydrochloride Tarceva 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral April 30, 2005 In Use
54868-5290-00 54868-5290 Erlotinib Hydrochloride Tarceva 25.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral July 1, 2005 In Use
54868-5447-00 54868-5447 Erlotinib Hydrochloride Tarceva 150.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor EGFR Oral Oct. 13, 2005 In Use
00179-0074-70 00179-0074 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 20, 2010 In Use
00555-0899-02 00555-0899 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
16590-0052-71 16590-0052 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Oct. 22, 1997 In Use
16590-0278-30 16590-0278 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
54569-4907-00 54569-4907 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54569-4907-02 54569-4907 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54569-4908-00 54569-4908 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral Oct. 28, 1997 In Use
54868-4030-00 54868-4030 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Sept. 18, 2000 In Use
54868-4030-01 54868-4030 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Sept. 18, 2000 In Use
54868-4030-02 54868-4030 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Sept. 18, 2000 In Use
54868-4031-00 54868-4031 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral May 7, 2003 In Use
54868-4031-01 54868-4031 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral May 7, 2003 In Use
54868-4031-02 54868-4031 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral May 7, 2003 In Use
54868-4031-03 54868-4031 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral May 7, 2003 In Use
55700-0458-30 55700-0458 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Nov. 18, 2016 In Use
55700-0458-90 55700-0458 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral Nov. 18, 2016 In Use
55700-0504-90 55700-0504 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral Feb. 17, 2017 In Use
63629-5208-01 63629-5208 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
63629-5208-02 63629-5208 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
63629-5208-03 63629-5208 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
63629-5208-04 63629-5208 Estradiol Estradiol 0.5 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
64205-0048-30 64205-0048 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
64205-0048-90 64205-0048 Estradiol Estradiol 1.0 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
64205-0488-30 64205-0488 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
64205-0488-90 64205-0488 Estradiol Estradiol 2.0 mg/1 Hormonal Therapy Estrogen Oral March 14, 1996 In Use
42023-0110-01 42023-0110 Estradiol Valerate Delestrogen 10.0 mg/mL Hormonal Therapy Estrogen Intramuscular Nov. 1, 2007 In Use
42023-0111-01 42023-0111 Estradiol Valerate Delestrogen 20.0 mg/mL Hormonal Therapy Estrogen Intramuscular Nov. 1, 2007 In Use
42023-0112-01 42023-0112 Estradiol Valerate Delestrogen 40.0 mg/mL Hormonal Therapy Estrogen Intramuscular Nov. 1, 2007 In Use
54569-0811-03 54569-0811 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Jan. 1, 2006 In Use
54569-0812-00 54569-0812 Estrogens, Conjugated Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan. 1, 2006 In Use
54569-0812-05 54569-0812 Estrogens, Conjugated Premarin 0.625 mg/1 Hormonal Therapy Estrogen Oral Jan. 1, 2006 In Use
54569-0813-01 54569-0813 Estrogens, Conjugated Premarin 1.25 mg/1 Hormonal Therapy Estrogen Oral Sept. 1, 2004 In Use
54868-2702-00 54868-2702 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Nov. 16, 2004 In Use
54868-2702-01 54868-2702 Estrogens, Conjugated Premarin 0.3 mg/1 Hormonal Therapy Estrogen Oral Nov. 16, 2004 In Use
55154-0219-08 55154-0219 Estrogens, Conjugated Premarin 0.9 mg/1 Hormonal Therapy Estrogen Oral Jan. 1, 2006 In Use
54868-5934-00 54868-5934 Estrogens, Esterified Menest 0.625 mg/1 Hormonal Therapy Estrogen Oral Sept. 5, 2008 In Use
54868-5934-01 54868-5934 Estrogens, Esterified Menest 0.625 mg/1 Hormonal Therapy Estrogen Oral Sept. 5, 2008 In Use
54868-6212-00 54868-6212 Estrogens, Esterified Menest 1.25 mg/1 Hormonal Therapy Estrogen Oral Dec. 16, 2010 In Use
54868-6212-01 54868-6212 Estrogens, Esterified Menest 1.25 mg/1 Hormonal Therapy Estrogen Oral Dec. 16, 2010 In Use
00378-3266-94 00378-3266 Etoposide Etoposide 50.0 mg/1 Chemotherapy Plant Alkaloid Epipodophyllotoxins Oral Oct. 22, 2001 In Use
00009-7663-04 00009-7663 Exemestane Aromasin 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral Oct. 21, 1999 In Use
00054-0080-13 00054-0080 Exemestane Exemestane 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 1, 2011 In Use
00832-0595-30 00832-0595 Exemestane Exemestane 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral July 27, 2017 In Use
54868-5261-00 54868-5261 Exemestane Aromasin 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral June 29, 2005 In Use
59762-2858-01 59762-2858 Exemestane Exemestane 25.0 mg/1 Hormonal Therapy Aromatase Inhibitor Oral April 1, 2011 In Use
63323-0145-07 63323-0145 Floxuridine Floxuridine 500.0 mg/5mL Chemotherapy Antimetabolite Pyrimidine Analog Intra-arterial March 15, 2001 In Use
25021-0242-02 25021-0242 Fludarabine phosphate Fludarabine phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Oct. 15, 2016 In Use
45963-0609-55 45963-0609 Fludarabine phosphate Fludarabine phosphate 50.0 mg/2mL Chemotherapy Antimetabolite Purine Analog Intravenous Jan. 5, 2015 In Use
66758-0046-01 66758-0046 Fludarabine Phosphate Fludarabine Phosphate 25.0 mg/mL Chemotherapy Antimetabolite Purine Analog Intravenous Oct. 12, 2007 In Use
00187-3204-47 00187-3204 Fluorouracil Efudex 2.0 g/40g Chemotherapy Antimetabolite Pyrimidine Analog Topical July 29, 1970 In Use
25021-0215-98 25021-0215 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Sept. 15, 2016 In Use
25021-0215-99 25021-0215 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Sept. 15, 2016 In Use
51672-4063-01 51672-4063 Fluorouracil Fluorouracil 50.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Topical Nov. 5, 2003 In Use
54868-6293-00 54868-6293 Fluorouracil Fluorouracil 50.0 mg/g Chemotherapy Antimetabolite Pyrimidine Analog Topical Sept. 6, 2011 In Use
69097-0915-12 69097-0915 Flutamide Flutamide 125.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Sept. 21, 2016 In Use
69097-0915-91 69097-0915 Flutamide Flutamide 125.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral Sept. 21, 2016 In Use
00002-7502-01 00002-7502 Gemcitabine hydrochloride Gemzar 1.0 g/25mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous May 22, 1996 In Use
55390-0391-10 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
55390-0391-50 55390-0391 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 40.0 mg/mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous March 19, 2012 In Use
68083-0148-01 68083-0148 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 200.0 mg/5mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Feb. 1, 2016 In Use
68083-0149-01 68083-0149 Gemcitabine Hydrochloride Gemcitabine Hydrochloride 1.0 g/25mL Chemotherapy Antimetabolite Pyrimidine Analog Intravenous Feb. 1, 2016 In Use
50090-2027-00 50090-2027 Goserelin acetate Zoladex 3.6 mg/1 Hormonal Therapy GnRH Agonist Subcutaneous Sept. 23, 2015 In Use
00009-0012-01 00009-0012 Hydrocortisone Cortef 5.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 15, 1952 In Use
00009-0031-01 00009-0031 Hydrocortisone Cortef 10.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 15, 1952 In Use
00009-0044-01 00009-0044 Hydrocortisone Cortef 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral Dec. 15, 1952 In Use
16590-0990-30 16590-0990 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 18, 1973 In Use
16590-0990-60 16590-0990 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 18, 1973 In Use
16590-0990-90 16590-0990 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral June 18, 1973 In Use
54868-1743-00 54868-1743 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 5, 2007 In Use
54868-1743-01 54868-1743 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 5, 2007 In Use
54868-1743-02 54868-1743 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 5, 2007 In Use
54868-1743-03 54868-1743 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 5, 2007 In Use
54868-1743-04 54868-1743 Hydrocortisone Hydrocortisone 20.0 mg/1 Hormonal Therapy Adrenal Glucocorticoid Corticosteroid Oral July 5, 2007 In Use

Found 10,000 results in 5 milliseconds — Export these results